
Human Melanocyte protein PMEL 613-626, SLIYRRRLMKQDFSV
Description
About Human Melanocyte protein PMEL 613-626, SLIYRRRLMKQDFSV
The Human Melanocyte protein Pmel 17 (gp100) Peptide (IEDB: 124726) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Melanocyte protein Pmel 17 (gp100) Peptide, H-SLIYRRRLMKQDFSV-OH (Uniprot: P40967 aa: 613-626) from JPT is produced under strict quality control and quality management.
Human Melanocyte protein PMEL 613-626, SLIYRRRLMKQDFSV - Specifications
- Peptide sequence: H-SLIYRRRLMKQDFSV-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Cancer, Epithelium, Melanoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Melanocyte protein PMEL 613-626, SLIYRRRLMKQDFSV
References:
Read References with JPT’s Antigen Peptides
Human Melanocyte protein PMEL 613-626, SLIYRRRLMKQDFSV has been described in:
T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis., Invest Ophthalmol Vis Sci, 2005 (PMID: 15980237)
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer., N Engl J Med, 2022 (PMID: 35648703)
Documentation
Documentation for Human Melanocyte protein PMEL 613-626, SLIYRRRLMKQDFSV
Properties
Properties of Human Melanocyte protein PMEL 613-626, SLIYRRRLMKQDFSV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Cancer, Epithelium, Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Melanocyte protein Pmel 17 (gp100) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Melanocyte protein PMEL 613-626, SLIYRRRLMKQDFSV
Information | Values |
---|---|
Sequence: | H-SLIYRRRLMKQDFSV-OH |
Specifications: | 15mer peptide as TFA salt |